LiftActiv Supreme Anti-Wrinkle Cream

About Vichy

In an industry obsessed with novelty, Vichy’s LiftActiv Supreme is impressive. It launched at the World Congress of Dermatology in Seoul in 2011 and remains on pharmacy shelves with nearly the same formulation fifteen years later. Vichy’s LiftActiv Supreme did not go viral or use celebrity ambassadors. It arrived with clinical data, seven patents, and a decade of L’Oréal research.

Reality

The active ingredient in this cream is rhamnose, a plant-derived sugar. Most consumers do not know it, but the science is interesting. Most anti-aging actives work on the epidermis or the reticular dermis. Rhamnose targets the papillary dermis—the thin layer between those two that supplies nutrients to the skin above. This layer thins with age, causing the skin above to lose structural support. L’Oréal’s research shows 5% rhamnose stimulates the papillary dermis to produce more collagen IV and procollagen I, thickening the layer that aging collapses. A randomized, double-blind study in the International Journal of Cosmetic Science confirmed these effects in vivo after eight weeks of twice-daily application.

Concentration matters. Rhamnose is fourth in the INCI list—behind water, glycerin, and dimethicone—at a confirmed 5%. This is not a trace amount behind preservatives. It is a meaningful dose of the active the product is named after. This alignment between marketing and formulation is rare in skincare.

Adenosine provides anti-wrinkle support. A L’Oréal Recherche study on 126 women aged 45-65, published in the International Journal of Cosmetic Science, showed significant improvements in periorbital skin smoothness within three weeks of adenosine application. It is one of the few anti-wrinkle ingredients with regulatory approval across multiple markets.

The texture reflects French pharmacy heritage. This cream feels like a more expensive product—a light, velvety formulation that melts into skin without the heaviness of most wrinkle-targeted moisturizers. The silicone base (dimethicone and vinyl dimethicone crosspolymers) creates a silky slip and a comfortable semi-matte finish. Bismuth oxychloride, titanium dioxide, and synthetic fluorphlogopite provide immediate optical smoothing; fine lines look softer before the rhamnose works. This strategy gives users visible results on day one so they continue using the product until the deeper actives deliver at week eight.

The scent is a light, clean, pharmacy-fresh accord. It is generally pleasant. Some users find it stronger than expected, which matters for those using fragrance-free formulations. Including fragrance in a product for mature, potentially sensitized skin prioritizes user experience over dermatological purity.

Alcohol denat. sits at sixth in the ingredient list. It helps the cream absorb quickly and creates a non-greasy finish, but its presence in a product for aging skin—which is often drier and more barrier-compromised—is notable. The concentration is roughly 2%, low enough to avoid major barrier disruption for most, but high enough to caution those with reactive or very dry skin. A separate dry skin variant exists without this, suggesting Vichy knows this limitation.

Isopropyl isostearate also requires mention. It is an emollient with known comedogenic potential; users prone to breakouts should note it. While acne may seem secondary for the 35+ demographic, adult acne is common, and ingredient awareness matters.

Vichy’s clinical data claims up to a 20% reduction in key facial wrinkles after eight weeks, tested on over 300 women across seven clinical studies. These numbers are well-documented and reasonable.

At roughly $45 for 50 mL, this cream is a premium pharmacy brand. The value lies in the research: 10 years of development, 7 patents, and a World Congress debut. You pay for a pharmacy-brand moisturizer developed with clinical rigor. Whether the same L’Oréal research appears in cheaper products from the parent company is for the consumer to check, but Vichy’s formulation uses a thermal water base, specific silicone architecture, and an optical finishing system to differentiate it from mass-market siblings.

This cream rewards patience and consistency. It is not flashy and does not erase ten years overnight. It offers measurable, patent-backed, clinically tested wrinkle reduction via an uncommon ingredient, in a texture that makes daily use feel like a small luxury. For a product nearing its fifteenth year, that is a strong resume.